Holen Sie sich die Stockscreener-App
13.42
1.13%
0.15
Handel nachbörslich:
13.65
0.23
+1.71%
Climb Bio Inc Aktie (CLYM) Neueste Nachrichten
5 Biotech Stocks That Delivered 100% To 300% Gains: Did Your Winning Trades Offset Portfolio Losses? - RTTNews
Form 4 Climb Bio Inc For: 1 July By Investing.com - Investing.com Canada
70,284 Climb Bio (CLYM) share options granted for RA Capital-related funds - Stock Titan
Climb Bio Appoints Breanna O’Reilly to Board - TipRanks
Climb Bio (CLYM) director receives 70,284 stock options tied to RA Capital funds - Stock Titan
Climb Bio (CLYM) director Breanna Maurine Celebi files initial Form 3 - Stock Titan
Breanna O’Reilly joins Climb Bio (NASDAQ: CLYM) board with stock option grant - Stock Titan
Climb Bio, Inc. reveals on-target clinical results for budoprutug in new study - Traders Union
Climb Bio Insider Sold Shares Worth $406,979, According to a Recent SEC Filing - marketscreener.com
Form 4 Climb Bio Inc For: 30 June By Investing.com - Investing.com Canada
Climb Bio CEO Aoife Brennan sells $406,979 in shares By Investing.com - Investing.com South Africa
Form 144 CLIMB BIO For: 30 June By Investing.com - Investing.com Australia
Climb Bio (CLYM) CEO sells 30,902 shares after RSU vesting - Stock Titan
[144] Climb Bio, Inc. SEC Filing - Stock Titan
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 2000 Index - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 2500 Growth Benchmark - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 2000 Value Benchmark - marketscreener.com
Climb Bio, Inc. advances rare kidney disease collaboration with patient-centered approach - Traders Union
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 2000 Growth Benchmark - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 3000E Growth Benchmark - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell 3000 Index - marketscreener.com
Climb Bio, Inc.(NasdaqGM: CLYM) added to Russell Small Cap Completeness Index - marketscreener.com
CLYM Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost DisciplineEarnings Expansion Phase - dars.gov.et
Why is Climb Bio stock gaining Friday? - MSN
Price to sales forward of Climb Bio, Inc. – NASDAQ:CLYM - TradingView
Price to earnings forward of Climb Bio, Inc. – NASDAQ:CLYM - TradingView
Price to book forward of Climb Bio, Inc. – NASDAQ:CLYM - TradingView
Climb Bio, Inc. Actuals & Estimates (NASDAQ:CLYM) - TradingView
NephCure Patient and Youth Summits partnership expands support for rare kidney disease patients - Traders Union
Raymond James Maintains Climb Bio(CLYM.US) With Buy Rating - Moomoo
S&P 500 Futures Climb in Premarket Trading; Bio-Techne, Micron Technology Lead - Barron's
Climb Bio stock price target reiterated at $20 by H.C. Wainwright - Investing.com UK
CLYM Reiterated by HC Wainwright & Co. -- Price Target Maintained at $20 - GuruFocus
Climb Bio stock price target reiterated at $20 by H.C. Wainwright By Investing.com - Investing.com India
H.C. Wainwright Maintains Climb Bio(CLYM.US) With Buy Rating, Maintains Target Price $20 - Moomoo
CLYM Q1 2026 Earnings: Narrower-than-expected loss highlights progress despite no revenueEarnings Revision Downgrade - dars.gov.et
CLYM News | CLIMB BIO INC (NASDAQ:CLYM) - ChartMill
Climb Bio Inc (CLYM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Climb Bio Inc (CLYM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Climb Bio Inc (CLYM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Climb Bio Inc (CLYM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Climb Bio Inc (CLYM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Climb Bio Inc (CLYM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Climb Bio Inc (CLYM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Climb Bio Inc (CLYM) Institutional Confidence - TradingKey
Climb Bio Inc (CLYM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Climb Bio (CLYM) and Intuitive Surgical (ISRG) - The Globe and Mail
CLYM Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineEarnings Surprise Stocks - newsline.com
Climb Bio teases key Budoprutug, CLYM116 readouts at BioConnect - MSN
Analysts Conflicted on These Healthcare Names: United Therapeutics (UTHR), DENTSPLY SIRONA (XRAY) and Climb Bio (CLYM) - The Globe and Mail
Wedbush Maintains Climb Bio(CLYM.US) With Buy Rating, Announces Target Price $17 - Moomoo
Climb Bio launches $100M at-the-market common stock offering - scanx.trade
Climb Bio Establishes New At-the-Market Equity Program - TipRanks
Climb BioEnters Open Market Sale Agreement With JefferiesSEC Filing - TradingView
Climb Bio Launches $100 Million ATM Equity Program With Jefferies - TradingView
1.18%
2.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):